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ABSTRACT In this paper we report a recessive mutation,
immune deficiency (imd), that impairs the inducibility of all
genes encoding antibacterial peptides during the immune
response of Drosophila. When challenged with bacteria, flies
carrying this mutation show a lower survival rate than
wild-type flies. We also report that, in contrast to the anti-
bacterial peptides, the antifungal peptide drosomycin remains
inducible in a homozygous imd mutant background. These
results point to the existence oftwo different pathways leading
to the expression of two types of target genes, encoding either
the antibacterial peptides or the antifungal peptide drosomy-
cin.
The powerful innate defense of higher insects involves pro-
teolytic cascades (coagulation and phenoloxidase cascades),
phagocytosis and encapsulation of invading microorganisms,
and the synthesis by the fat body of a battery of potent
antimicrobial peptides (reviewed in refs. 1 and 2). In Drosoph-
ila, several genes encoding inducible antibacterial peptides
[cecropins (3, 4); diptericin (5); defensin (6); drosocin (7); M.
Charlet, personal communication] and one inducible antifun-
gal peptide [drosomycin (8); L.M. and J.-M.R., unpublished
results] have been cloned. Understanding the mechanism of
the coordinate control of their expression after immune chal-
lenge (e.g., septic injury) is a major goal in the field. Significant
similarities exist between the control of antimicrobial peptide
gene expression in insects and that of acute phase response
genes in mammals (reviewed in refs. 1 and 2). This is illustrated
by the involvement of common cis-regulatory motifs in the
promoters of most of the insect and mammalian immune genes
[e.g., NF-KB and NF-IL6 response elements, interferon con-
sensus regulatory sequences (9-11)]. Furthermore, members
of the Rel/NF-KB family play a crucial role in the transacti-
vation of mammalian acute phase response genes; similarly,
Rel proteins have been recently implicated in the control of the
immune genes in Drosophila (12, 13) as the genes encoding the
two Rel proteins dorsal (dl) and Dif (dorsal-related immune
factor) are up-regulated in the fat body upon immune chal-
lenge and both proteins are translocated in the nucleus (refs.
12 and 13; B.L. and E.N., unpublished results). The precise
roles of these proteins in the immune response of Drosophila
are not yet established (discussed in refs. 14 and 15).
While analyzing the expression of antibacterial genes in a
mutant of the phenoloxidase cascade, we have found, by
serendipity, a recessive mutation, immune deficiency (imd),
that impairs the inducibility of the antibacterial peptides
described so far in Drosophila. When challenged with bacteria,
flies carrying this mutation show a lower survival rate than
wild-type flies. We also report that, in contrast to the anti-
bacterial peptides, the antifungal peptide drosomycin remains
inducible in a homozygous imd mutant background. These
results point to the existence of two different pathways leading
either to the expression of the genes encoding antibacterial
peptides or to the expression of the drosomycin gene.
MATERIALS AND METHODS
Drosophila Stocks and Culture Medium. OregonR flies were
used as a standard wild-type strain. The transgenic strain,
Dipt2.2-lacZ:1, is a ry56 C.S. line carrying a diptericin reporter
gene on the X chromosome (5). The fusion gene contains 2.2
kb of diptericin upstream sequences fused to the bacterial lacZ
coding region and was inserted into the Carnegie 20 vector
(16). The developmental and the inducible expression of the
Dipt2.2-lacZ transgene has been described (5, 17); it is similar
to that of the resident diptericin gene at the end of the third
larval instar.
1046Bc is a line homozygous for the Bc (Black cells)
mutation (18, 19) obtained from the Bloomington Stock
Center (Bloomington, IN). Deficiency lines are described in
ref. 20.
Stocks and crosses were maintained on a standard corn meal
medium. All experiments were performed at 25°C unless
otherwise stated. For complete descriptions of the marker
genes and balancer chromosomes, see ref. 20.
Bacterial Challenge. Bacterial challenge was performed by
pricking third instar larvae, pupae, or adults with a thin needle
previously dipped into a concentrated bacterial culture of
Escherichia coli and Micrococcus luteus.
(3-Galactosidase Localization. The fat bodies were dissected
in phosphate-buffered saline and treated as described in ref.
21.
RNA Preparation and Analysis. Crosses were performed at
25°C and wandering third instar larvae, 24- to 48-h pupae, or
2- to 4-day-old adult flies were collected. Total RNA extrac-
tion and Northern blotting experiments were performed as in
ref. 15. The following probes were used: diptericin cDNA (22),
drosocin cDNA (7), drosomycin cDNA (8), rp49 cDNA [a
PCR fragment of -400 bp generated between two oligonu-
cleotides designed after the rp49 coding sequence (23)], a
21-mer oligonucleotide (5'-GATTCCCAGTCCCTGGAT-
TGT-3') complementary to part of the coding sequence of
cecropin Al, which is identical for cecropin A2 (3). Poly(A)
RNA extraction was prepared as in ref. 15 except that extrac-
tion of total RNA was performed with the RNA Trizol
(GIBCO/BRL) method.
Preparation of Extracts and Electrophoretic Mobility Shift
Assay. The method was that described in ref. 10. In short, 10
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jig of protein extracts from control and bacteria-challenged
adult males were incubated with 20,000 cpm (2 fmol) of a
labeled 16-bp double-stranded probe containing a KB-related
motif (5'-ATCGGGGATTCCTTTT-3') for 15 min at room
temperature, and were analyzed in a standard gel-shift assay.
RESULTS
Characterization of immune deficiency (imd), a Mutation
That Alters the Inducible Expression of the Genes Encoding
Antibacterial Peptides. The initial part of this study was based
on a fly line, 1046Bc, obtained from the Bloomington Stock
Center, that probably corresponds to the original Bc (Black
cells) line isolated by Grell after ethyl methanesulfonate
mutagenesis in 1969 (ref. 18; K. Matthews, personal commu-
nication). Bc is a second chromosome mutation that is ho-
mozygous viable. The most striking phenotype of homozygous
and heterozygous Bc mutants is the presence of circulating
melanized crystal cells in larvae (19). Phenoloxidase activity is
undetectable in the cell-free hemolymph of Bc/Bc larvae (19).
We have also observed that the 1046Bc line exhibits a ther-
mosensitive tumor phenotype; larvae raised above 21°C have
a high frequency of melanotic tumors and a higher than normal
hemocyte count (data not shown).
When challenging homozygous 1046Bc flies with bacteria,
we observed that the expression of the antibacterial peptide
genes was severely impaired. In fact, as will be demonstrated
below, this impairment was independent from the Bc mutation
but was due to a closely related, as yet undescribed, mutation,
which we call immune deficiency (imd). We will refer to the fly
line presenting the Bc and the immune deficiency phenotypes
as Bc,imd hereafter.
We first studied by a transgenic approach the expression of
the diptericin gene, which encodes an antibacterial peptide.
We have performed histochemical staining of the fat body in
larvae carrying a transgene in which 2.2 kb of upstream
sequences of the diptericin gene are fused to the lacZ reporter
gene (Dipt2.2-lacZ:1; see ref. 5). We constructed a fly line
carrying the reporter transgene and the Bc,imd mutations by
standard crosses. Fig. 1 illustrates the 13-galactosidase activity
(5-bromo-4-chloro-3-indolyl ,B-D-galactoside staining reac-
tion) in the fat body of challenged wild-type larvae and
homozygous Bc,imd mutant larvae; a deep blue coloration is
apparent in all fat body cells of the wild-type larvae, whereas
only a reduced number of cells shows a weak expression of the
a b
FIG. 1. Induction of a diptericin-lacZ reporter gene in challenged
wild-type and homozygous Bc,imd mutant larvae. Histochemical
staining of 0-galactosidase activity is shown in the fat body of a 4-h
bacteria-challenged diptericin-lacZ transgenic larva (a) and of a 4-h
challenged transgenic larva carrying the homozygous Bc,imd mutation
(b). Both stainings were performed in the same run of experiments.
(x20.)
transgene in the mutant fat body. In challenged mutant adults,
in contrast to wild type, only a faint level of expression was
observed in the fat body (data not shown).
We have corroborated these results by an analysis of the
expression of all previously identified Drosophila genes encod-
ing antibacterial peptides. Total RNAs from larvae, pupae,
and adults of control and challenged wild-type and Bc,imd
mutants were probed with cDNAs corresponding to diptericin,
drosocin, and cecropin A (encoded by the CecAl and the
CecA2 genes; see ref. 3), rp49 serving as a control. In wild-type
animals, the four genes were strongly induced at all stages. In
striking contrast, the induction was severely impaired for all
four genes in Bc,imd mutant larvae, pupae, and adults (Fig. 2
a and b). However, the inducibility was not totally abolished,
as a low hybridization signal remained detectable in challenged
mutants, particularly for cecropin A transcripts. Radioactivity
measurements indicated that the overall reduction in the level
of inducibility was -10-fold with some variability among
different genes. Heterozygous Bc,imd/+ larvae and adults
retained a full inducibility of the diptericin gene after chal-
lenge (Fig. 2c; data not shown).
In Drosophila, the gene encoding insect defensin is induced
at a significantly lower level than that of the other antibacterial
genes. We asked whether its induction was also affected in the
Bc,imd background. Poly(A)-enriched RNA from challenged
and unchallenged wild-type and Bc,imd larvae and adults was
prepared and probed with defensin cDNA. Fig. 3 shows that
the inducibility of the defensin gene was also abolished in
mutant larvae and adults.
We next studied in Bc,imd mutants the expression of the
drosomycin gene, which encodes an antifungal peptide. North-
ern blots were probed with drosomycin cDNA and, as shown
in Fig. 2 a and b, the inducibility of this gene by bacterial
challenge was unaffected in Bc,imd background, indicating
that at least two distinct control pathways exist for induction
of antimicrobial (antibacterial/antifungal) peptides.
The fact that the impaired induction of the antibacterial
genes was not related to the Bc mutation but to a closely linked
mutation was established by the analysis of deficiencies and,
finally, by recombination of the two mutations. Deficiency
Df(2R)PC4, which deletes the 55A-55F interval, uncovers the
Bc mutation (mapped at 55A; ref. 20) and imd. However, two
more limited deficiencies, Df(2R)Pc1-7B and Df(2R)Pcl-11B
(deleting 54E8-F1;55B9-C1 and 54F6-55A1;55C1-3, respec-
tively), which also uncover the Bc mutation (20), did not
uncover the imd mutation, which alters the immune response.
imd was therefore mapped to the 55C-55F interval. Finally, a
series of recombination experiments has enabled us to map the
imd mutation at 3.5% from the Bc mutation (based on seven
recombinants).
We have repeated the most significant experiments on the
impairment of the inducible expression of antibacterial pep-
tides with recombinant homozygous imd flies, lacking the Bc
mutation. The results were identical (data not shown), in
Northern blot analyses and 13-galactosidase staining, to those
presented above. Homozygous imd flies did not generate a
melanotic tumor phenotype nor any other striking morpho-
logical defects. Conversely, homozygous recombinant Bc mu-
tants (devoid of the imd mutation) showed a wild-type induc-
ibility of antibacterial peptide genes and also exhibited the
thermosensitive melanotic tumor phenotype previously ob-
served (see above). We have not yet clarified whether this
phenotype is directly related to the Bc mutation or to a
mutation proximal to Bc.
Protein Extracts from imd Homozygous Mutants Bind
Poorly to cB-Related Nucleotide Sequence Motifs. The genes
encoding inducible antibacterial peptides that have been char-
acterized so far in Drosophila all contain KB-related sequence
motifs in their promoters. These sequences have been shown
to confer bacteria inducibility to the diptericin and cecropin
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FIG. 2. Transcriptional profiles of diptericin, drosocin, cecropin A, and drosomycin in wild-type and Bc,imd mutant Drosophila. Total RNA was
extracted at different time intervals (as indicated) after septic injury from wild-type OregonR (OrR), Bc,imd homozygous, and Bc,imd/+
heterozygous mutants. Twenty-microgram samples were fractionated by denaturing 1% agarose/formaldehyde gel electrophoresis, transferred onto
a nylon membrane, and successively hybridized with nick-translated cDNA probes (Dipt, diptericin; Drc, drosocin; Drom, drosomycin; rp49) and
an oligonucleotide probe (Cec, cecropin A). 13, wandering stage third instar larvae; P, 24- to 48-h-old pupae; 48- to 72-h adults. Adults were used
in c. a, b, and c were obtained separately.
genes by experiments based on transgenic fly lines and trans-
fection of an immune-responsive blood cell line (9, 10). Protein
extracts from challenged but not from naive insects form a
major complex with the KB-related sequences of the promoters
of both genes in electrophoretic mobility shift assays. We were
curious to determine if the alteration of the antibacterial
response in imd mutants was correlated to a defect in the
formation of this protein-DNA complex. We used a labeled
oligonucleotide containing a diptericin KB-related motif in
electrophoretic mobility shift assays with nuclear protein
extracts from control and bacteria-challenged wild-type and
imd male adults. As previously reported (i0), bacterial chal-
lenge induces a strong DNA-binding activity in extracts of
wild-type Drosophila, but only a weak binding activity was
L3
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detectable in our experimental conditions with extracts from
imd flies (Fig. 4).
Susceptibility ofimd Homozygous Mutants to Septic Injury.
To our knowledge, imd is the first mutation known to alter the
induction of genes encoding antibacterial peptides. We were
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FIG. 3. Transcriptional profiles of defensin in wild-type and Bc,imd
mutant Drosophila. Poly(A) RNA was extracted at different time
intervals (as indicated) after septic injury from wild-type OregonR
(OrR) or Bc,imd homozygous mutants. Five-microgram samples were
fractionated by denaturing 1% agarose/formaldehyde gel electro-
phoresis, transferred onto a nylon membrane, and successively hybrid-
ized with nick-translated defensin (Def) and rp49 cDNA probes.
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FIG. 4. DNA-protein binding activity in nuclear extracts of wild-
type and homozygous imd mutant Drosophila. Control (c) or 6-h
bacteria-challenged OregonR (OrR) or mutant (imd/imd) male adults
were sacrificed and the corresponding nuclear protein extracts were
incubated in the presence of a KB-related 16-bp radioactive oligonu-
cleotide probe (10). The specificity of the binding activity was ascer-
tained by competition assays with excess of native or mutated probe
(data not shown).
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FIG. 5. Survival of wild-type and homozygous imd mutant male
adults after immune challenge. The survival levels after bacterial
challenge of imd/imd, Bc/Bc, and Bc,md/Bc,imnd mutants and of
wild-type (OrR) flies are displayed with their confidence intervals (P
< 0.05). Groups of 25-30 adults, aged 2-4 days, were challenged and
transferred to a fresh vial every 4 days. When tested in the same
conditions, the survival levels of unchallenged imd/imd, Bc/Bc, and
Bc,imd/Bc,imnd mutants were identical to that observed with wild-type
line (>95% after 10 days). At least 20 replicates were used for the
determination of the survival levels.
interested to determine if imd homozygous flies were more
sensitive to bacterial infection than wild-type flies. Groups of
20-25 mutant and wild-type adults were subjected to bacterial
challenge and their survival was monitored over a 10-day
period. As shown in Fig. 5, challenged imd/imd mutants
exhibited a slight but significantly lower level of s'urvival after
septic injury. Ten days after treatment, around 70% of the
imd/imd males survived compared to >90% of wild-type
males. This lower survival rate does not reflect a generally
decreased level of viability since the survival is not affected in
unchallenged imd adults over a 10-day period (see legend to
Fig. 5). Heterozygote adults presented a survival rate after
challenge that was similar to that of wild-type flies (data not
shown). Interestingly, homozygous Bc,imd flies showed a very
low level of survival. Four days after treatment, <40% of the
Bc,imd/Bc,imd males survived. This low level probably reflects
the contribution of both mutations, since adults carrying only
the Bc mutation show also a lower' than wild-type level of
survival, comparable to that of imd mutants (Fig. 5).
DISCUSSION
In this paper we report. a recessive mutation that impairs the
inducibility of the genes encoding antibacterial peptides during
the immune response of Drosophila. This mutation, imd for
immune deficiency, was found by serendipity, linked to the Bc
mutation, in the Bloomington Bc stock. We did not observe an
additional phenotype in imd mutants.
To date, the genes encoding cecropins, diptericin, drosocin
(all predominantly active against Gram-negative bacteria), and
insect defensin (active against Gram-positive bacteria), have
been characterized in Drosophila (reviewed in refs. 1, 2, and
24). These genes are expressed with acute phase kinetics
following bacterial challenge, although their expression pat-
terns s4ow some variability. It is significant that the four genes
are affected in homozygous imd flies and that they all show an
inducibility which is reduced roughly 10-fold. This result
indicates that the coordinate expression of these genes shares
a common pathway in which the imd+ product -is a crucial
element. It is of interest to note in this context that the
promoters of these genes all contain a certain number of
common cis-regulatory sequences, among which KB-related
motifs appear to play a pivotal role in the inducibility, as has
been demonstrated in the case of the diptericin and cecropin
genes (9, 10). As oligonucleotides containing a KB-related
sequence fail to form a detectable complex with nuclear
extracts from immune-challenged imd mutant flies, in contrast
to wild-type challenged flies, the imd+ product either is a
component of this complex or is required for the formation of
the complex. The cloning of the imd gene is an obvious goal
that will presumably clarify this problem.
Our data on the survival rate of imd mutants lend credit to the
relevance of the inducible antibacterial peptides in the host
defense ofDrosophila. Clearly, survival of the bacteria-challenged
insects is reduced when the induction of the antibacterial peptide
genes is impaired. However, the involvement of other defense
mechanisms, such as phagocytosis or the low level of antibacterial
peptides still present in mutant flies, may account for the survival
of a high proportion of challenged imd mutants. Interestingly, our
data also support the long-standing idea that the prophenol
oxidase cascade plays a role in the host defense, as judged from
the decreased survival rates ofBc mutants. As the lines used were
not isogenic, we cannot exclude that the survival rate could also
have been affected by other unrelated mutations. Isolation ofnew
inmd alleles by mutagenesis should clarify this point and reveal
whether the imd gene's product is involved in additional biological
processes.
A surprising result was the observation that in imd. mutants,
the drosomycin gene, in contrast to the antibacterial peptide
genes, retains its full inducibility. This gene encodes a peptide
that has a marked sequence homology to plant antifungal
peptides and indeed exhibits a high in vitro activity against
fungi (8). TIhis result indicates that two distinct regulatory
cascades lead to the expression of the antimicrobial genes.
Altfiough in this study, we were limited to the only inducible
gene encoding an antifungal peptide characterized so far in
Drosophila, we propose that the two regulatory pathways
correspond indeed to two distinct functional defense responses
directed against either bacteria or fungi.
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